First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer. Initiation of trial sites underway for ground ...

Complicated scenarios, however, put forward new challenges for path planning of multiple UAVs; therefore, a novel cylindrical coordinate particle swarm optimization (PSO) planner with gene targeting ...

OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: OXB) (the ...

The Adeno Associated Virus Vector Manufacturing market, valued at USD 1,148.4 million in 2024, is expected to register robust revenue CAGR of 19.6%.Request free copy of this report:  March 14, 2025 - ...

Kincell Bio, a cell therapy developer and manufacturer, has appointed Larry Pitcher as Chief Operating Officer (COO).

Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders. Now it’s on the cusp of its first regulatory approval. Each year ...

Ltd, and Westlake Laboratory of Life Sciences and Biomedicine report a pre-clinical study that evaluates the safety and efficacy of SIN-IL2RG-LV vector-based gene therapy for X-SCID. Using next ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for $4.3 billion in 2019. Roche described the restructuring in ...

Boston biotech Beam Therapeutics has announced initial data from a phase 1/2 trial of its gene therapy for a genetic lung and liver disease, with no serious adverse events reported among the nine ...

“This is the beginning of a new era of medicine,” said Dr. Kiran Musunuru, a gene therapy researcher at the University of Pennsylvania’s Perelman School of Medicine. He added that the method ...

The seemingly mysterious deaths of Gene Hackman and his wife, Betsy Arakawa, in their Santa Fe, N.M., home were both natural and occurred days apart before they were discovered, authorities ...

The University of Bristol research team used animal models to compare patient responses to AAV therapy, studying male and female eye cells across different age groups (young, middle-aged and older ...